Assoc. Prof. Dr. Tanja Dudenbostel | Endocrinology | Assistant Professor at University of Alabama at Birmingham | United States
Endocrinology expert Assoc. Prof. Dr. Tanja Dudenbostel is an accomplished Assistant Professor at the University of Alabama at Birmingham, United States, widely recognized for her impactful contributions to endocrine and metabolic research. Assoc. Prof. Dr. Tanja Dudenbostel completed advanced medical and academic training in endocrinology-related disciplines, forming a strong foundation for translational and clinical research. Professionally, Assoc. Prof. Dr. Tanja Dudenbostel is actively engaged in academic teaching, clinical investigation, and high-impact scientific publishing. Her research interests focus on hormonal regulation, metabolic disorders, cardiometabolic risk, and endocrine mechanisms underlying chronic diseases. Her research skills include clinical research design, data analysis, biomarker evaluation, and evidence-based endocrinology. With more than two thousand citations, an h-index of 25, and a strong i10-index, Assoc. Prof. Dr. Tanja Dudenbostel has earned notable academic recognition. In conclusion, Assoc. Prof. Dr. Tanja Dudenbostel is a leading Endocrinology scholar whose research excellence continues to advance clinical understanding and patient-centered endocrine care.
Citation Metrics (Google Scholar)
2500
2000
1500
1000
500
0
.
.
🟦 Citations 🟥 Documents 🟩 h-index
View Google Scholar Profile
Featured Publications
Refractory hypertension: definition, prevalence, and patient characteristics
– The Journal of Clinical Hypertension, 2012
Resistant hypertension, obstructive sleep apnoea and aldosterone
– Journal of Human Hypertension, 2012
Refractory hypertension: evidence of heightened sympathetic activity as a cause of antihypertensive treatment failure
– Hypertension, 2015
Effects of antihypertensive drugs on arterial stiffness
– Cardiology in Review, 2012
Refractory hypertension: a novel phenotype of antihypertensive treatment failure
– Hypertension, 2016
Prevalence and clinical characteristics of refractory hypertension
– Journal of the American Heart Association, 2017
Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease
– Journal of Human Hypertension, 2012